Blumhouse Productions seems determined to move forward with its new Exorcist trilogy, despite the recent commercial failure of The Exorcist: Believer. This latest installment grossed $136 million worldwide, a result that, although it suggests a relative success on a budget of $30 million, does not meet the expectations of entertainment giants Universal and Peacock, who shelled out $400 million for the rights to the trilogy.
A movie that has not met expectations
To revitalize this iconic horror franchise, Blumhouse has taken bold steps by recruiting renowned director Mike Flanagan, known for his expertise in creating successful sequels, such as The Origin of Evil and Doctor Sleep. Flanagan, who recently captivated audiences with The Life of Chuck, will incorporate his innovative vision to attract both horror fans and new generations of viewers.
The most surprising news is the casting of Scarlett Johansson as the lead in the upcoming installment. Johansson, one of the most prominent actresses in the industry, brings a new dimension to the project, generating expectations about how her involvement may influence both the narrative and the box office. As the audience awaits more details about the script and the characters, interest in this new chapter of The Exorcist intensifies.
Blumhouse’s strategy to continue with the trilogy, despite the evident financial risks, reflects an unwavering faith in the franchise’s potential and in Flanagan’s ability to restore it to its former glory. With the public’s eyes on this new creative direction, it will be fascinating to see how the story unfolds and whether it will succeed in reviving the legacy of horror that The Exorcist has represented over the decades.